Merck & Co.’s Keytruda/Inlyta Combo Invades Kidney Cancer Territory

 
• By Alexandra Shimmings
  
Military
Merck & Co. Is Marching On Another New Indication
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer